GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (HKSE:02359) » Definitions » Effective Interest Rate on Debt %

Wuxi AppTec Co (HKSE:02359) Effective Interest Rate on Debt % : 4.61% (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Wuxi AppTec Co Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Wuxi AppTec Co's annualized positive value of Interest Expense for the quarter that ended in Mar. 2025 was HK$282 Mil. Wuxi AppTec Co's average total debt for the quarter that ended in Mar. 2025 was HK$6,121 Mil. Therefore, Wuxi AppTec Co's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2025 was 4.61%.


Wuxi AppTec Co Effective Interest Rate on Debt % Historical Data

The historical data trend for Wuxi AppTec Co's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuxi AppTec Co Effective Interest Rate on Debt % Chart

Wuxi AppTec Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.94 1.61 2.04 0.91 3.96

Wuxi AppTec Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.17 3.13 2.45 4.27 4.61

Competitive Comparison of Wuxi AppTec Co's Effective Interest Rate on Debt %

For the Diagnostics & Research subindustry, Wuxi AppTec Co's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuxi AppTec Co's Effective Interest Rate on Debt % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Wuxi AppTec Co's Effective Interest Rate on Debt % falls into.


;
;

Wuxi AppTec Co Effective Interest Rate on Debt % Calculation

Wuxi AppTec Co's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2023 )+Total Debt  (A: Dec. 2024 ))/ count )
=-1  *  -230.653/( (6286.676+5347.816)/ 2 )
=-1  *  -230.653/5817.246
=3.96 %

where

Total Debt  (A: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=1953.018 + 4333.658
=6286.676

Total Debt  (A: Dec. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=3743.333 + 1604.483
=5347.816

Wuxi AppTec Co's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2025 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Dec. 2024 )+Total Debt  (Q: Mar. 2025 ))/ count )
=-1  *  -282.04/( (5347.816+6894.358)/ 2 )
=-1  *  -282.04/6121.087
=4.61 %

where

Total Debt  (Q: Dec. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=3743.333 + 1604.483
=5347.816

Total Debt  (Q: Mar. 2025 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=1489.417 + 5404.941
=6894.358

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Mar. 2025) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Wuxi AppTec Co  (HKSE:02359) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Wuxi AppTec Co Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Wuxi AppTec Co's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuxi AppTec Co Business Description

Traded in Other Exchanges
Address
288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by China, Europe, and other regions.
Executives
Ubs Group Ag 2201 Interest of corporation controlled by you
Computershare Hong Kong Trustees Limited 2301 Trustee
Jpmorgan Chase & Co.
Fmr Llc 2201 Interest of corporation controlled by you
Invesco Advisers, Inc. 2102 Investment manager
Blackrock, Inc. 2201 Interest of corporation controlled by you
Morgan Stanley 2201 Interest of corporation controlled by you
Citigroup Inc. 2201 Interest of corporation controlled by you
Schroders Plc 2102 Investment manager
The Capital Group Companies, Inc. 2201 Interest of corporation controlled by you
The Goldman Sachs Group, Inc.
Brown Brothers Harriman & Co. 2502 Approved lending agent
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Fil Limited 2201 Interest of corporation controlled by you

Wuxi AppTec Co Headlines

No Headlines